Correlation Between Biofrontera Warrants and Connect Biopharma
Can any of the company-specific risk be diversified away by investing in both Biofrontera Warrants and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofrontera Warrants and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofrontera Warrants and Connect Biopharma Holdings, you can compare the effects of market volatilities on Biofrontera Warrants and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofrontera Warrants with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofrontera Warrants and Connect Biopharma.
Diversification Opportunities for Biofrontera Warrants and Connect Biopharma
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Biofrontera and Connect is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Biofrontera Warrants and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Biofrontera Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofrontera Warrants are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Biofrontera Warrants i.e., Biofrontera Warrants and Connect Biopharma go up and down completely randomly.
Pair Corralation between Biofrontera Warrants and Connect Biopharma
Assuming the 90 days horizon Biofrontera Warrants is expected to generate 31.07 times more return on investment than Connect Biopharma. However, Biofrontera Warrants is 31.07 times more volatile than Connect Biopharma Holdings. It trades about 0.2 of its potential returns per unit of risk. Connect Biopharma Holdings is currently generating about -0.03 per unit of risk. If you would invest 0.00 in Biofrontera Warrants on September 4, 2024 and sell it today you would earn a total of 8.25 from holding Biofrontera Warrants or generate 9.223372036854776E16% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 78.13% |
Values | Daily Returns |
Biofrontera Warrants vs. Connect Biopharma Holdings
Performance |
Timeline |
Biofrontera Warrants |
Connect Biopharma |
Biofrontera Warrants and Connect Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Biofrontera Warrants and Connect Biopharma
The main advantage of trading using opposite Biofrontera Warrants and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofrontera Warrants position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.Biofrontera Warrants vs. Biofrontera | Biofrontera Warrants vs. Pasithea Therapeutics Corp | Biofrontera Warrants vs. Inspira Technologies Oxy | Biofrontera Warrants vs. Bluejay Diagnostics |
Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |